NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Healx

Healx

Private
CambridgeHealthcare & Life Scienceshttps://healx.ai/

Last Round

Series C

Aug 1, 2024

Total Funding Raised

$114.9M

Company Overview

Healx is a biotechnology company that utilizes artificial intelligence-driven drug discovery technology to develop treatments for rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

drug discoveryAI drug discoveryrare disease researchdrug repurposingbiotechin silico drug discoverymulti-omicsclinical-stage biotechtherapeutic developmentAI-powered medicinevirtual screeningdrug pipelinebiomedical datachemically-aware LLMspharma partnerships

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Healx Comparables

Compare Healx with similar companies based on industry and business-model similarity.

Healx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SOM Biotech
84%
Delta4
82%
Purposeful
82%

Healx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 1, 2024
Series BOct 16, 2019
Series AJul 26, 2018
SeedOct 4, 2016

Key People

Founding team and executive leadership

Tim Guilliams

Co-founder, CEO

Founding Team

Healx Investors

Notable investors and investment history

Healx investors
InvestorRounds
Amadeus Capital PartnersSeries A, Series B, Seed
o2h venturesSeries C
Global Brain CorporationSeries C, Series B
Intel CapitalSeries B
b2ventureSeries C, Series B
VU Venture PartnersSeries C
AtomicoSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2025

    Partnered with Vuja De Sciences to focus on oncology.

  • Jul 1, 2025

    Drug candidates have entered clinical trials, indicating a clinical-stage development.

Healx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Healx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Healx's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range69
Year Founded2014
Last FundingAug 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.